STSS: Sharps Technology, Inc. Long-Term Debt Volume

Graphic logo of Sharps Technology Inc (STSS)

Sharps Technology, Inc. (STSS) focuses on developing high-tech syringes with reuse protection, investing in biocompatible materials and precision molding. Market fluctuations in the share price confirm interest in the asset, where the long-term debt metric stands at 0.00. The brand is implementing safety standards to minimize the risk of accidental needlestick injuries to medical professionals. Management is currently scaling production for a full-scale market entry, awaiting the execution of the first major deals.

STSS Sharps Technology Inc: Company Long-Term Debts in the range 04/28/2023 - 05/28/2026

Analytical breakdowns for Sharps Technology, Inc.

- price and consensus price forecast:
Share Price Sharps Technology Inc|STSS - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Sharps Technology, Inc.|STSS - Enterprise Value
- book capitalization data:
Accounting Value per Share Sharps Technology, Inc.|STSS - Book Capitalization|Market Capitalization to Book Value Ratio sharpstechnology.com|STSS - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Sharps Technology, Inc.|STSS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Sharps Technology Inc|STSS - Company Aggregate Debts|Debts to Net Assets Sharps Technology, Inc.|STSS - Company Long-Term Debt|Company Short-Term Indebtedness Sharps Technology, Inc.
General company analysis:Sharps Technology, Inc. (STSS)
Mass-produced product of Sharps Tech

Sharps Technology, Inc. (STSS) specializes in creating robotic assembly lines for sterile syringes, minimizing manual labor. Analyzing the company's long-term debt chart, an investor can observe the daily price action of borrowed obligations, which is critical for assessing the credit load. This indicator measures total long-term liabilities, allowing for the determination of the balance between financial leverage and liquidity. Optimizing this metric confirms the sustainability of capital expenditures in production automation.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Monogram Technologies Inc - Company Long-Term Liabilities|INFU: Company Long-Term Debts|UTMD (Utah Medical Products) - Company Long-Term Debt|KORU Medical (KRMD) - Company Long-Term Liabilities|Company Long-Term Debts NYXH (Nyxoah)|Long-Term Debt MBOT|Company Long-Term Debt Pro-Dex Corp PDEX|Company Long-Term Indebtedness Zentek Corp ZTEK|Company Long-Term Liabilities Elutia Inc. (ELUT)|milestonescientific.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP: Long-Term Debt Volume|Harvard Bioscience, Inc. - Company Long-Term Debt|Femasys Corporation (FEMY) - Long-Term Debt Volume|MHUA - Company Long-Term Debts|Company Long-Term Loans and Borrowings Predictive Oncology Corp|Company Long-Term Debts CJMB|Company Long-Term Debts ATRI (Atrion Corp.)|Company Long-Term Debt NeuroMetrix Corp